Coronary Artery Disease: Causes, Symptoms, and Progression
Coronary artery disease (CAD) is the leading cause of death in the United States, accounting for approximately 1 in 5 deaths according to the Centers for Disease Control and Prevention (CDC). It develops when the arteries that supply blood to the heart muscle become narrowed or blocked, restricting oxygen delivery to cardiac tissue. This page covers the definition and scope of CAD, the biological mechanisms that drive its progression, the clinical scenarios in which it presents, and the boundaries that distinguish CAD subtypes and severity classifications.
Definition and Scope
Coronary artery disease is defined by the National Heart, Lung, and Blood Institute (NHLBI) as a condition in which plaque — composed of cholesterol, fatty substances, calcium, and cellular waste — accumulates within the walls of the coronary arteries, reducing or obstructing blood flow to the myocardium. This process, termed atherosclerosis, can affect one or all three of the major coronary vessels: the left anterior descending artery, the right coronary artery, and the left circumflex artery.
The CDC estimates that approximately 18.2 million adults in the United States have coronary artery disease (CDC, Heart Disease Facts). The condition exists on a spectrum from subclinical plaque accumulation — detectable only by imaging — to obstructive disease that limits perfusion at rest. The American Heart Association (AHA) classifies CAD within the broader category of atherosclerotic cardiovascular disease (ASCVD), a framework used to guide both risk stratification and treatment thresholds across clinical practice guidelines.
For context on how cardiology as a specialty approaches disease classification and treatment authority, the regulatory-context-for-cardiology page outlines the governing bodies, licensing standards, and quality frameworks that shape CAD care delivery in the United States.
How It Works
Atherosclerosis begins with endothelial dysfunction — damage to the thin inner lining of the coronary artery wall. Risk factors including hypertension, elevated low-density lipoprotein (LDL) cholesterol, cigarette smoking, diabetes mellitus, and chronic inflammation injure the endothelium, making it permeable to circulating lipoproteins.
The biological sequence unfolds in four identifiable phases:
- Endothelial injury — mechanical stress, oxidized LDL, or inflammatory cytokines compromise the arterial lining, triggering adhesion molecule expression.
- Lipid infiltration and oxidation — LDL particles accumulate in the subendothelial space and undergo oxidative modification, attracting monocytes from the bloodstream.
- Foam cell formation and plaque development — monocytes differentiate into macrophages, engulf oxidized LDL, and become lipid-laden foam cells. Over time, these cells aggregate into a fatty streak, then a fibrous plaque with a lipid-rich necrotic core covered by a fibrous cap.
- Plaque instability and rupture — thin-capped fibroatheromas are vulnerable to rupture. When a plaque ruptures, the exposed necrotic core triggers thrombus formation, which can partially or completely occlude the vessel lumen within minutes.
The NHLBI identifies the degree of luminal stenosis as a primary determinant of ischemic burden. A stenosis of 70% or greater in a major coronary artery is generally considered hemodynamically significant and consistent with obstructive CAD. Fractional flow reserve (FFR) measurement, performed during cardiac catheterization and angiography, provides a functional assessment of whether a stenosis is causing ischemia, independent of its anatomical appearance.
Common Scenarios
CAD presents across three distinct clinical patterns, each reflecting a different relationship between plaque burden and myocardial oxygen supply:
Stable Angina (Chronic Coronary Syndrome)
In stable CAD, a fixed stenosis limits blood flow during exertion but not at rest. Patients typically describe chest tightness, pressure, or discomfort that occurs predictably with physical activity or emotional stress and resolves within minutes of rest or nitroglycerin administration. The AHA/ACC 2023 Guideline for the Diagnosis and Management of Chronic Coronary Disease defines this presentation as chronic coronary syndrome and recommends risk stratification using non-invasive testing before proceeding to invasive assessment. Tools such as cardiac stress testing and CT coronary angiography are central to this evaluation pathway.
Acute Coronary Syndrome (ACS)
ACS encompasses unstable angina, non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). All three involve plaque rupture or erosion and acute thrombus formation. STEMI, characterized by complete occlusion of a coronary artery, requires emergent reperfusion — typically within 90 minutes of first medical contact for primary percutaneous coronary intervention, per the ACC/AHA STEMI Guidelines. Biomarkers including high-sensitivity troponin I and troponin T are the primary laboratory tools for distinguishing ACS types; these are detailed under blood tests for heart disease.
Silent Ischemia
A subset of patients with significant CAD experience no anginal symptoms despite measurable reductions in myocardial perfusion during stress. The ACC estimates silent ischemia may affect up to one-third of patients with obstructive CAD. Ambulatory monitoring and nuclear cardiology imaging are used to detect this pattern in high-risk populations.
Decision Boundaries
Distinguishing CAD severity and subtype requires structured classification. The primary boundaries used in clinical practice draw from AHA/ACC guidelines and the SYNTAX score system for anatomical complexity:
| Classification | Defining Feature | Typical Intervention Threshold |
|---|---|---|
| Non-obstructive CAD | Stenosis < 50% in all vessels | Medical therapy; risk factor modification |
| Single-vessel obstructive CAD | ≥ 70% stenosis in one major vessel | Angioplasty and stenting or medical therapy |
| Multivessel CAD | ≥ 70% stenosis in ≥ 2 major vessels | SYNTAX score guides stenting vs. bypass surgery |
| Left main CAD | ≥ 50% stenosis of left main artery | Typically surgical revascularization |
The SYNTAX score, developed as part of the SYNTAX trial published in the New England Journal of Medicine, assigns numerical complexity values to coronary lesion burden. A SYNTAX score above 32 generally favors surgical revascularization over percutaneous intervention based on outcomes data.
Risk stratification for primary prevention relies on the Pooled Cohort Equations, endorsed by the ACC/AHA 2019 Primary Prevention Guidelines, which estimate 10-year ASCVD risk and guide statin therapy initiation thresholds. Patients with an estimated 10-year risk of 7.5% or greater are generally considered candidates for moderate-intensity statin therapy.
A comprehensive overview of the cardiovascular system underlying these disease mechanisms is available at cardiologyauthority.com/index, which maps the full scope of conditions and specialty areas addressed across this reference network.
References
- Centers for Disease Control and Prevention — Heart Disease Facts
- National Heart, Lung, and Blood Institute — Coronary Heart Disease
- American Heart Association — Coronary Artery Disease
- ACC/AHA 2023 Guideline for the Diagnosis and Management of Chronic Coronary Disease (JACC)
- ACC/AHA 2019 Guideline on the Primary Prevention of Cardiovascular Disease (Circulation)
- ACC/AHA STEMI Guideline (Circulation)
- American College of Cardiology
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)